Marshall Islands vs Palau: The number of people with susceptibility test result for rifampicin
Marshall Islands
100
in 2021
Palau
100
in 2021
Marshall Islands rank
2nd
Palau rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Marshall Islands
- Palau
How they compare
Marshall Islands currently reports 100 against 100 in Palau, a difference of 0.
Across all 5 years both countries report, Palau has been ahead every year.
Marshall Islands ranks 2nd and Palau ranks 2nd of 146 countries.
Palau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | Palau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 96.97 | 100 | 3.03 | Palau |
| 2020s | 87.04 | 100 | 12.96 | Palau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Marshall Islands or Palau?
- Marshall Islands, at 100 against 100 in Palau as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Marshall Islands and Palau?
- 0, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Palau?
- 5 years are reported by both, from 2017 to 2021.
- How do Marshall Islands and Palau rank globally for the number of people with susceptibility test result for rifampicin?
- Marshall Islands ranks 2nd and Palau ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.